Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice
Foy, Teresa M. ; McIlraith, Melissa ; Masters, Sally R. ; Dunn, Jonathan J. ; Rossini, Aldo A. ; Shultz, Leonard D. ; Hesselton, RuthAnn M. ; Wagar, Eric James ; Lipsky, Peter E. ; Noelle, Randolph J. ... show 1 more
Foy, Teresa M.
McIlraith, Melissa
Masters, Sally R.
Dunn, Jonathan J.
Rossini, Aldo A.
Shultz, Leonard D.
Hesselton, RuthAnn M.
Wagar, Eric James
Lipsky, Peter E.
Noelle, Randolph J.
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
1998-03-07
Keywords
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
Antibodies to the ligand for CD40 (CD154) have been shown to exert profound effects on the development of cell-mediated immune responses in mice. The present study shows that an antibody to human CD154 (hCD40L) inhibits in vivo Tetanus toxoid (TT) specific secondary antibody responses in hu-PBL-scid mice, as well as the expansion of xenoreactive human T cells in the scid mice. A possible cause for the reduced expansion of xenoreactive, human T cells, was the decreased expression of murine B7.1 and B7.2 caused by the administration of anti-hCD40L. Therefore, it may be that defective maturation of murine antigen-presenting cells impeded the priming and expansion of human xenoreactive T cells.
Source
Cell Transplant. 1998 Jan-Feb;7(1):25-35.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/S0963-6897(97)00113-9
Permanent Link to this Item
PubMed ID
9489760